LAMIFLO Trademark

Trademark Overview


On Friday, December 6, 2019, a trademark application was filed for LAMIFLO with the United States Patent and Trademark Office. The USPTO has given the LAMIFLO trademark a serial number of 88717898. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 22, 2021. This trademark is owned by ShearIT, LLC. The LAMIFLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of humans and animals, namely, pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease and veterinary pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease; Pharmaceutical preparations for treating brain ischemia; Pharmaceuticals for the treatment of cerebrovascular disease; Pharmaceutical agents affecting brain perfusion or blood flow
lamiflo

General Information


Serial Number88717898
Word MarkLAMIFLO
Filing DateFriday, December 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of humans and animals, namely, pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease and veterinary pharmaceutical preparations for the treatment of myocardial ischemia, peripheral limb ischemia as may occur in diabetic neuropathy, muscle compartmentation syndrome, decubitus, hemorrhagic shock and acute and chronic kidney disease; Pharmaceutical preparations for treating brain ischemia; Pharmaceuticals for the treatment of cerebrovascular disease; Pharmaceutical agents affecting brain perfusion or blood flow
Pseudo MarkLAMI FLO
Pseudo MarkLAMI FLOW

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShearIT, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAlbuquerque, NM 87102

Party NameShearIT, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAlbuquerque, NM 87102

Trademark Events


Event DateEvent Description
Monday, March 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 14, 2020ASSIGNED TO LIE
Monday, May 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 11, 2020EXAMINER'S AMENDMENT ENTERED
Monday, May 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 11, 2020EXAMINERS AMENDMENT E-MAILED
Monday, May 11, 2020EXAMINERS AMENDMENT -WRITTEN
Saturday, March 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 21, 2020NON-FINAL ACTION E-MAILED
Saturday, March 21, 2020NON-FINAL ACTION WRITTEN
Saturday, March 7, 2020ASSIGNED TO EXAMINER
Wednesday, December 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 10, 2019NEW APPLICATION ENTERED IN TRAM